Completed Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis NCT02641457 Conditions Eye Diseases, Glaucoma, Ocular Hypertension, +1 more Locations Instituto de Olhos de Goiania — Goiânia, Goiás, Brazil View Trial Details
Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy NCT00470977 Conditions Abnormalities, Multiple, Angiomatosis, BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder), +45 more Locations Lenox Hill Hospital/Manhattan Eye Ear and Throat Institute — New York, United States Lenox Hill Hospital/Manhattan Eye, Ear & Throat Institute — New York, United States View Trial Details
Completed Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery NCT01069341 Conditions Cataract, Eye Diseases, Lens Diseases, +2 more Locations Njms / Umdnj — Newark, New Jersey, United States View Trial Details
Completed Intraocular Bevacizumab (Avastin) for Rubeosis Iridis NCT00557232 Conditions Eye Diseases, Glaucoma, Ocular Hypertension, +1 more Locations Not specified View Trial Details
